Table of Contents

Section
Page Number Ligand Synthesis 3 Scheme S1. Synthesis of 1 6 Scheme S2. Synthesis of Nat Zr-1 8 Figure S1 . ESI-MS analysis of Nat Zr-1 9 Scheme S3. Radiochemical synthesis of 89 Zr-1 10 Figure S2 . HPLC quality control analysis of 89 Zr-1 11 Table S1 . In vitro stability: 50mM DTPA challenge 12 Table S2 . In vitro stability: Human serum challenge 12 Table S3 . Biodistribution of 89 Zr-1 13 Table S4 . Analytical data for 
MATERIALS AND METHODS
Ligand Synthesis
Electrospray ionization (ESI) high-resolution mass spectra (HRMS) were obtained by the Mass Spectrometry Facility, College of Chemistry, University of California, Berkeley, CA. Flash chromatography was performed using EM Science Silica Gel 60 (230 -400 mesh). NMR spectra were obtained using either Bruker AM-300 or AV-600 spectrometers operating at 300 (75) MHz and 600 (150) MHz for For the deprotected macrocycles 1 and 2, the observed NMR spectra were very complicated due to the presence of differing conformers/isomers in solution, and are not reported. 3 Analytical HPLC was performed on an Agilent 1200 instrument (Agilent, Santa Clara, CA) equipped with a diode array detector (λ = 280 or 315 nm, 600 nm reference), a thermostat set at 25 °C, and a Zorbax Eclipse XDB-C18 column (4.6 x 150 mm, 5 µm, Agilent, Santa Clara, CA). The mobile phase of a binary gradient (Method 1: 2-40% B/20 min; solvent A, 0.1% TFA; solvent B, ACN or Method 2: 10-60% B) at a flow rate of 1 mL/min was used for analytical HPLC. All compounds were ≥95% pure. 3-(Benzyloxy)-6-methyl-1-(2-oxo-2-(2-
hexylcarbamic acid tert-butyl ester 6 were prepared as previously described. [1] [2] [3] Unless otherwise noted, all other chemicals were purchased from Sigma-Aldrich Chemical Co. (St. Louis, MO USA), and solutions were prepared using ultrapure water (18 MΩ-cm resistivity).
Synthesis of di-macrocycle 1 (Scheme S1). Overview: An excess of di-thiazolide 3 was condensed with N-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy] diethylenetriamine 4 to provide the activated di-amide 5, which was reacted with amine 6 under high dilution conditions to form the regioisomeric di-macrocycles 7 and 8.
Protective groups were removed using a solution of concentrated hydrochloric acid in acetic acid to provide dimacrocycles 1 and 2. The structures of 1 and 2 were assigned from fragmentation patterns using tandem mass spectrometry. Lower Rf isomer 8 was isolated in poorer yield; as a result, biological studies were not conducted using derivative 2. Benzyl and tert-butyloxycarbonyl-protected di-macrocycles 7 and 8. A solution of N,N′′-bis[3-benzyloxy-1- isopropyl alcohol (ca. 5%), and diisopropylethylamine (ca. 3%) (50 mL) were added dropwise to dichloromethane (2 L) over a period of four days using two syringe pumps at a rate of 0.5 mL/hr. After an additional two days of reaction, solvent was removed under reduced pressure, and the crude products were purified by silica gel chromatography using 0.1% triethylamine, 5 -7.5% methanol in dichloromethane as eluents. The silica gel column was prepared so as to have a short section (ca. 1.25") of aluminum oxide (basic, pressure, and the residue dried in vacuo to provide the protected di-macrocycles 7 (202 mg, 22.7%) and 8 (78 mg, 8.7%). The residue containing lower Rf compound 8 was additionally dissolved in dichloromethane (10 mL) and washed with water (2 x 10 mL) to remove triethylammonium salts prior to yield calculation. Di-macrocycle 1. Benzyl and tert-butyloxycarbonyl-protected di-macrocycle 7 (51 mg, 25 µmol) was dissolved in 12N hydrochloric acid (1.0 mL) and glacial acetic acid (1.0 mL). The solution was stirred under inert atmosphere for 23 hr, whereupon HCl was removed with a stream of inert gas. Solvents were removed under reduced pressure and the residue was dried in vacuo. The residue was dissolved in methanol (600 + 300 µL) and transferred to two O-ring microcentrifuge tubes. Ether (ca. 1.5 mL) was added, and the tubes were placed at 4 o C for 1 hr. The tubes were centrifuged at 12,000 rpm for 3 minutes, decanted, the pellets were washed with ether (ca. 1.5 mL) and allowed to air dry. The pellets were dried in vacuo to provide di-macrocycle 7, pentahydrochloride salt (39.8 mg, 90% Zr-1 in selected organs at 2, 4, 24, 48, and 72 h p.i. 
